These findings imply that SLC25A28 plays a modulatory function in the adipocyte hypertrophy phenotype induction, thereby displaying possible therapeutic significance in obesity treatment and glucose metabolism. The gene discussed is SLC25A28; the disease is obesity due to melanocortin 4 receptor deficiency.